AbbVie dodges whistleblower''s patent fraud suit over Alzheimer''s drugs
AbbVie Inc has avoided, for now, a whistleblower lawsuit claiming that its predecessor Allergan Inc used fraudulent patents to extend its monopoly on Alzheimer''s drugs, allowing it to overcharge Medicare and Medicaid.
AbbVie dodges whistleblower''s patent fraud suit over Alzheimer''s drugs
AbbVie Inc has avoided, for now, a whistleblower lawsuit claiming that its predecessor Allergan Inc used fraudulent patents to extend its monopoly on Alzheimer''s drugs, allowing it to overcharge Medicare and Medicaid.